Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
Clinical trial NCT02877212 · UNKNOWN
Trial details
- NCT number
- NCT02877212
- Sponsor
- National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-07-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.